|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Sinha D, Biswas J, Sung B, Aggarwal BB and
Bishayee A: Chemopreventive and chemotherapeutic potential of
curcumin in breast cancer. Curr Drug Targets. 13:1799–1819. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Allgayer H and Fulda S: An introduction to
molecular targeted therapy of cancer. Adva Med Sci. 53:130–138.
2008.PubMed/NCBI
|
|
4
|
Pickart CM and Eddins MJ: Ubiquitin:
structures, functions, mechanisms. Biochim Biophys Acta.
1695:55–72. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pickart CM and Fushman D: Polyubiquitin
chains: polymeric protein signals. Curr Opin Chem Biol. 8:610–616.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ohta T and Fukuda M: Ubiquitin and breast
cancer. Oncogene. 23:2079–2088. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wilkinson KD: Regulation of
ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J.
11:1245–1256. 1997.PubMed/NCBI
|
|
8
|
Nijman SM, Luna-Vargas MP, Velds A, et al:
A genomic and functional inventory of deubiquitinating enzymes.
Cell. 123:773–786. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reyes-Turcu FE, Ventii KH and Wilkinson
KD: Regulation and cellular roles of ubiquitin-specific
deubiquitinating enzymes. Annu Rev Biochem. 78:363–397. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Makarova OV, Makarov EM and Luhrmann R:
The 65 and 110 kDa SR-related proteins of the U4/U6. U5 tri-snRNP
are essential for the assembly of mature spliceosomes. EMBO J.
20:2553–2563. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
van Leuken RJ, Luna-Vargas MP, Sixma TK,
Wolthuis RM and Medema RH: Usp39 is essential for mitotic spindle
checkpoint integrity and controls mRNA-levels of aurora B. Cell
Cycle. 7:2710–2719. 2008.PubMed/NCBI
|
|
12
|
Rios Y, Melmed S, Lin S and Liu NA:
Zebrafish usp39 mutation leads to rb1 mRNA splicing defect and
pituitary lineage expansion. PLoS Genet. 7:e10012712011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Izquierdo M: Short interfering RNAs as a
tool for cancer gene therapy. Cancer Gene Ther. 12:217–227. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qin XF, An DS, Chen IS and Baltimore D:
Inhibiting HIV-1 infection in human T cells by lentiviral-mediated
delivery of small interfering RNA against CCR5. Proc Natl Acad Sci
USA. 100:183–188. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen X, Zhang B and Fischer JA: A specific
protein substrate for a deubiquitinating enzyme: liquid facets is
the substrate of Fat facets. Genes Dev. 16:289–294. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sakurai M, Ayukawa K, Setsuie R, et al:
Ubiquitin C-terminal hydrolase L1 regulates the morphology of
neural progenitor cells and modulates their differentiation. J Cell
Sci. 119:162–171. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang JM: Emerging roles of
deubiquitinating enzymes in human cancer. Acta Pharmacologica Sin.
28:1325–1330. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Paulsson K, Békassy AN, Olofsson T,
Mitelman F, Johansson B and Panagopoulos I: A novel and
cytogenetically cryptic t(7;21)(p22;q22) in acute myeloid leukemia
results in fusion of RUNX1 with the ubiquitin-specific
protease gene USP42. Leukemia. 20:224–229. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim J, Kim WJ, Liu Z, Loda M and Freeman
MR: The ubiquitin-specific protease USP2a enhances tumor
progression by targeting cyclin A1 in bladder cancer. Cell Cycle.
11:1123–1130. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stevenson LF, Sparks A, Allende-Vega N,
Xirodimas DP, Lane DP and Saville MK: The deubiquitinating enzyme
USP2a regulates the p53 pathway by targeting Mdm2. EMBO J.
26:976–986. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nijman SM, Huang TT, Dirac AM, et al: The
deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway.
Mol Cell. 17:331–339. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang TT, Nijman SM, Mirchandani KD, et
al: Regulation of monoubiquitinated PCNA by DUB autocleavage. Nat
Cell Biol. 8:339–347. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang D, Zaugg K, Mak TW and Elledge SJ: A
role for the deubiquitinating enzyme USP28 in control of the
DNA-damage response. Cell. 126:529–542. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Popov N, Herold S, Llamazares M, Schulein
C and Eilers M: Fbw7 and Usp28 regulate myc protein stability in
response to DNA damage. Cell Cycle. 6:2327–2331. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schoenfeld AR, Apgar S, Dolios G, Wang R
and Aaronson SA: BRCA2 is ubiquitinated in vivo and interacts with
USP11, a deubiquitinating enzyme that exhibits prosurvival function
in the cellular response to DNA damage. Mol Cell Biol.
24:7444–7455. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li M, Chen D, Shiloh A, et al:
Deubiquitination of p53 by HAUSP is an important pathway for p53
stabilization. Nature. 416:648–653. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cummins JM, Rago C, Kohli M, Kinzler KW,
Lengauer C and Vogelstein B: Tumour suppression: disruption of
HAUSP gene stabilizes p53. Nature. 428:1 p following 486. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yuan J, Luo K, Zhang L, Cheville JC and
Lou Z: USP10 regulates p53 localization and stability by
deubiquitinating p53. Cell. 140:384–396. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lygerou Z, Christophides G and Seraphin B:
A novel genetic screen for snRNP assembly factors in yeast
identifies a conserved protein, Sad1p, also required for pre-mRNA
splicing. Mol Cell Biol. 19:2008–2020. 1999.PubMed/NCBI
|
